Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02394509 · ClinicalTrials.gov registry record · NA
HOBSCOTCH Phase II
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT02394509 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 106 participants.
The verdict
NCT02394509, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility and efficacy of the home-based cognitive self-management program "HOBSCOTCH" delivered at four New England medical centers. It will test the long-term impact and cost-effectiveness of HOBSCOTCH, and whether it can be delivered from a distance utilizing e-health tools for parts of the program.
Interventions
- BEHAVIORAL Home Based Self-management and Cognitive Training Changes lives (HOBSCOTCH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2015-03 |
| Est. Completion | 2019-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02394509
The ClinicalTrials.gov registry entry for NCT02394509 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Home Based Self-management and Cognitive Training Changes lives (HOBSCOTCH) is the first listed.
NCT02394509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02394509 about?
NCT02394509 is a clinical study titled "HOBSCOTCH Phase II". The purpose of this study is to determine the feasibility and efficacy of the home-based cognitive self-management program "HOBSCOTCH" delivered at four New England medical centers. It will test the long-term impact and cost-effectiveness of HOBSCOTCH, and whether it can be delivered from a distance...
What is the current status of trial NCT02394509?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2015-03. Estimated completion is 2019-09.
What interventions are being tested in trial NCT02394509?
The interventions under investigation include: Home Based Self-management and Cognitive Training Changes lives (HOBSCOTCH) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02394509?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.